Press & Media

ACTRIMS welcomes media participation at the Forum 2026! Complimentary press passes are available upon approval of credentials.

Apply & Submit Credentials

Eligibility

Complimentary press passes are available to working journalists who provide the appropriate credentials. Any reporter, writer, producer, editor, photographer, or blogger with credentials from a print, online, or broadcast news organization, including freelance journalists, will be considered.

Companies or organizations producing publications, videos, and other products intended for marketing, advertising, financial analysis, or public relations purposes may not register for press passes. This includes any organization that intends to sell or distribute content for profit and/or continuing education (CE) opportunities.

Returning Press

Returning press members who were registered for the ACTRIMS Forum 2025 will receive an email with a complimentary registration code by Wednesday, October 1, 2025, to register for the Forum 2026. Use this code to register on our website. If your credentials have changed, please upload them here. If you haven't received your complimentary code by the specified date above, contact us at info@actrims.org for assistance.

New Press

New press members must complete the online application form and submit one of the following credentials for review:

  • A letter of assignment or intent on official letterhead

  • A copy of a press or business card clearly showing media affiliation

  • Recent copies of published bylined medical-related work

Bloggers seeking press passes must work for a media outlet, publication, or independent website or blog that has original coverage and must demonstrate they have been writing regular posts at least 4 months prior to the conference.

  • The following embargo policies are strictly enforced. Failure by media organizations to abide by the embargoes will result in suspension of press passes, which will affect access privileges to current and future abstracts presented at ACTRIMS programs.

    ABSTRACT EMBARGO
    All accepted abstracts will be published in the ACTRIMS Forum 2026 Abstract Catalog and the Multiple Sclerosis Journal online.

    • Full text of Regular Abstracts is embargoed until published on Monday, January 26, 2026.

    • Full text of Cutting Edge Session Abstracts is embargoed until published on Thursday, February 05, 2026.

    • Full text of Late-Breaking Abstracts is embargoed until published on Saturday, February 7, 2026.

    PRESS RELEASE POLICY
    Press releases related to abstracts accepted for presentation are strictly prohibited until published in the ACTRIMS Forum 2026 Abstract Catalog. See Abstract Embargo dates above.

    Press releases that contain featured research and presentation data outside of the abstract are strictly prohibited until presented at the Forum.

    Investigators or study sponsors who wish to issue press releases that contain no actual presentation data but provide “topline” information in advance of the embargo date will need the approval of the Program Committee, who may require changes before permitting release. ACTRIMS does not review all outside press releases but will hold those representatives responsible for any misrepresentation.

    Press releases that feature news related to the Forum should include the full name of the meeting: the ACTRIMS Forum 2026.

    SOCIAL MEDIA POLICY
    Sharing news and information about the ACTRIMS Forum 2026 through social media is encouraged within the embargo restrictions. Please use the official hashtag in all posts: #ACTRIMSForum

  • All press events and scheduled interviews with Forum speakers or attendees must receive written pre-approval from ACTRIMS no later than Monday, January 26, 2026. Please ensure that events and interviews do not confict with the Forum general sessions. See the Program for full details.

    For interview requests and secondary sources, please contact Karisa Trudgeon at ktrudgeon@actrims.org. Media must obtain approval from an abstract author or presenter before quoting or publishing scientific results.

    To help maintain the schedule and out of respect for the presenters, please do not approach the stage before or after sessions. If your question is not addressed during the Q&A, please contact Karisa Trudgeon at ktrudgeon@actrims.org.

    All registered press are invited and expected to attend the Press Conference on Thursday, February 5, 2026.

    ACTRIMS reserves the right to revoke press passes for non-compliance with these policies. Additionally, ACTRIMS may request copies of any video interviews conducted onsite.

  • ACTRIMS and/or affiliated trademarks and logos, including the Forum logo, are the property of ACTRIMS. They cannot be used, reproduced, or associated with any article or press release without the prior written permission of ACTRIMS.

  • Share your excitement for the Forum 2026 on social media! Remember to use the official hashtag (#ACTRIMSForum) to help others discover what is being posted about the Forum!

    Example:

    • I'm excited to bring you the latest in MS research and care from the #ACTRIMSForum 2026, February 5 - 7, in San Diego! https://forum.actrims.org

  • Registered press members have access to the Press & Media Portal. This portal includes press materials, policies, and information for attending the Forum 2026 in San Diego. Click here to access the portal.